Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 2 2 Phase 4 1 Phase 3 1

Status

Completed 32 Unknown 7 Terminated 3 Withdrawn 1 Recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 6 Papillomavirus Infections 6 Neoplasms 6 Polycystic Ovary Syndrome 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Tuberous Sclerosis 2 Thyroid Neoplasms 2 Stomach Neoplasms 2 Smoking Cessation 2 Sarcoma 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Graft vs Host Disease 2 Dupuytren Contracture 2 Diabetes Mellitus 2 Dementia 2 Cardiovascular Diseases 2 Carcinoma, Hepatocellular 2 Wrist Fractures 1 Vaccine-Preventable Diseases 1 Uterine Cervical Neoplasms 1 Tobacco Use Cessation 1 Thyroid Diseases 1 Thalassemia 1

Interventions

tirbanibulin 1 Ointments 1 Gels 1 Diclofenac 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Active not recruiting × Keratosis, Actinic × Clear all

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡